You have full text access to this OnlineOpen article

Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on β-amyloid-induced toxicity in PC12 cells

  1. Teresa Iuvone,
  2. Giuseppe Esposito,
  3. Ramona Esposito,
  4. Rita Santamaria,
  5. Massimo Di Rosa,
  6. Angelo A. Izzo

Article first published online: 3 FEB 2004

DOI: 10.1111/j.1471-4159.2003.02327.x

Issue

Journal of Neurochemistry

Journal of Neurochemistry

Volume 89, Issue 1, pages 134–141, April 2004

Additional Information

How to Cite

Iuvone, T., Esposito, G., Esposito, R., Santamaria, R., Di Rosa, M. and Izzo, A. A. (2004), Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on β-amyloid-induced toxicity in PC12 cells. Journal of Neurochemistry, 89: 134–141. doi: 10.1111/j.1471-4159.2003.02327.x

Author Information

  1. Department of Experimental Pharmacology, University of Naples Federico II, Naples, Italy

*Address correspondence and reprint requests to Giuseppe Esposito or Angelo A. Izzo, Department of Experimental Pharmacology, University of Naples Federico II, via D. Montesano 49, 80131 Naples, Italy. E-mail: giuesp@interfree.it; aaizzo@unina.it

Publication History

  1. Issue published online: 10 MAR 2004
  2. Article first published online: 3 FEB 2004
  3. Received July 17, 2003; revised manuscript received November 27, 2003; accepted November 28, 2003.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (227K)

References

  • Bass D. A., Parce J. W., Dechatelet L. R., Szejda P., Seeds M. C. and Thomas M. (1983) Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130, 1910–1917.
  • Behl C., Davis J. B., Lesley R. and Shubert D. (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817–827.
  • Bisogno T., Hanus L., De Petrocellis L., Tchilibon S., Ponde D. E., Brandi I., Moriello A. S., Davis J. B., Mechoulam R. and Di Marzo V. (2001) Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br. J. Pharmacol. 134, 845–852.
    Direct Link:
  • Braak H. and Braak E. (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18, 351–357.
  • Brera B., Serrano A. and De Ceballos M. L. (2000) Beta-amyloid peptides are cytotoxic to astrocytes in culture: a role for oxidative stress. Neurobiol. Dis. 7, 395–405.
  • Caricasole A., Copani A., Caruso A., Caraci F., Iacovelli L., Sortino M. A., Terstappen G. C. and Nicoletti F. (2003) The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimer's disease? Trends Pharmacol. Sci. 24, 233–238.
  • Carlson G. A. (2003) A welcoming environment for amyloid plaques. Nat. Neurosci. 6, 328–330.
  • Cash A. D., Perry G. and Smith M. A. (2002) Therapeutic potential in Alzheimer disease. Curr. Med. Chem. 9, 1605–1610.
  • Chen Y. and Buck J. (2000) Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism. J. Pharmacol. Exp. Ther. 293, 807–812.
  • Consroe P., Laguna J., Allender J., Snider S., Stern L., Sandyk R., Kennedy K. and Schram K. (1991) Controlled clinical trial of cannabidiol in Huntington's disease. Pharmacol. Biochem. Behav. 40, 701–708.
  • Cotman C. W., Tenner A. J. and Cummings B. J. (1996) β-Amyloid converts an acute phase injury response to chronic injury responses. Neurobiol. Aging 17, 723–731.
  • Cunha J. M., Carlini E. A., Pereira A. E., Ramos O. L., Pimentel C., Gagliardi R., Sanvito W. L., Lander N. and Mechoulam R. (1980) Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology 21, 175–185.
  • Esposito G., Izzo A. A., Di Rosa M. and Iuvone T. (2001) Selective cannabinoid CB1 receptor-mediated inhibition of inducible nitric oxide synthase protein expression in C6 rat glioma cells. J. Neurochem. 78, 835–841.
    Direct Link:
  • Esposito G., Ligresti A., Izzo A. A., Bisogno T., Ruvo M., Di Rosa M., Di Marzo V. and Iuvone T. (2002) The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity. Mechanism and regulation. J. Biol. Chem. 277, 50348–50354.
  • Gervais F. G., Xu D., Robertson G. S. et al. (1999) Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 97, 395–406.
  • Golde T. E. (2003) Alzheimer disease therapy: can the amyloid cascade be halted? J. Clin. Invest. 111, 11–18.
  • Green K. N. and Peers C. (2002) Divergent pathways account for two distinct effects of amyloid beta peptides on exocytosis and Ca(2+) currents: involvement of ROS and NF-kappaB. J. Neurochem. 81, 1043–1051.
    Direct Link:
  • Grundy R. I., Rabuffetti M. and Beltramo M. (2001) Cannabinoids and neuroprotection. Mol. Neurobiol. 24, 29–51.
  • Gschwind M. and Huber G. (1995) Apoptotic cell death induced by β-amyloid1−42 peptide is cell type dependent. J. Neurochem. 65, 292–300.
    Direct Link:
  • Guan Z. Z., Yu W. F. and Nordberg A. (2003) Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells. Neurochem. Int. 43, 243–249.
  • Hampson A. J., Grimaldi M., Axelrod J. and Wink D. (1998) Cannabidiol and (-) Δ9-tetrahydrocannabinol are neuroprotective antioxidants. Proc. Natl Acad. Sci. USA 95, 8268–8273.
  • Hampson A. J., Grimaldi M., Lolic M., Wink D., Rosenthal R. and Axelrod J. (2000) Neuroprotective antioxidants from marijuana. Ann. NY Acad. Sci. 899, 274–282.
    Direct Link:
  • Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R. A. and Butterfield D. A. (1994) A model for beta amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl Acad. Sci. USA 91, 3270–3274.
  • Itagaki S., McGeer P. L., Akiyama H., Zhu S. and Selkoe D. (1989) Relationship of microglia and astrocytes to amyloid deposits of Alzheimer desease. J. Neuroimmunol. 24, 173–182.
  • Jacobsson S. O., Rongard E., Stridh M., Tiger G. and Fowler C. J. (2000) Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability. Biochem. Pharmacol. 60, 1807–1813.
  • Kokoszka J. E., Coskun P., Esposito L. A. and Wallace D. C. (2001) Increased mitochondrial oxidative stress in the Sod2 (+/–) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis. Proc. Natl Acad. Sci. USA 98, 2278–2283.
  • Koo E. H., Lansbury P. T. and Kelly J. W. (1999) Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc. Natl Acad. Sci. USA 96, 9989–9990.
  • Le Bel C., Ischiropoulos H. and Bondy S. C. (1992) Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5, 227–231.
  • Lee V. M. Y., Balin B. J., Otvos L. and Trojanowski J. Q. (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 251, 675–678.
  • Markesbery W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134–147.
  • Marsicano G., Moosmann B., Hermann H., Lutz B. and Behl C. (2002) Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J. Neurochem. 80, 448–456.
    Direct Link:
  • Martin D., Salinas M., Lopez-Valdaliso R., Serrano E., Recuero M. and Cuadrado A. (2001) Effect of the Alzheimer amyloid fragment Abeta(25–35) on Akt/PKB kinase and survival of PC12 cells. J. Neurochem. 78, 1000–1008.
    Direct Link:
  • Marx J. (2001) Neuroscience. New leads on the ‘how’ of Alzheimer's. Science 293, 2192–2194.
  • Mattson M. P. (2002) Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease. J. Neurovirol. 8, 539–550.
  • Mattson M. P., Lovell M. A., Ehmann W. D. and Markesbery W. R. (1993) Comparison of the effects of elevated intracellular aluminum and calcium levels on neuronal survival and tau immunoreactivity. Brain Res. 602, 21–31.
  • Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I. and Rydel R. E. (1992) beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376–389.
  • Mechoulam R., Parker L. A. and Gallily R. (2002) Cannabidiol: an overview of some pharmacological aspects. J. Clin. Pharmacol. 42, 11S–19S.
  • Mihara M. and Uchiama M. (1978) Determination of malonaldheyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86, 271–278.
  • Milton N. G. (2002) Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. Neurosci. Lett. 332, 127–130.
  • Molderings G. J., Bonisch H., Hammermann R., Gothert M. and Bruss M. (2002) Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha2 and CB1 receptors: similarities to presynaptic imidazoline and edg receptors. Neurochem. Int. 40, 157–167.
  • Mosman T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Meth 65, 53–63.
  • Nicholson D. W. and Thornberry N. A. (1997) Caspases: killer proteases. Trends Biochem. Sci. 22, 299–306.
  • Nocerino E., Amato M. and Izzo A. A. (2000) Cannabis and cannabinoid receptors. Fitoterapia 71, S6–S12.
  • Onoue S., Endo K., Ohshima K., Yajima T. and Kashimoto K. (2002) The neuropeptide PACAP attenuates beta-amyloid (1–42)-induced toxicity in PC12 cells. Peptides 23, 1471–1478.
  • Pertwee R. G. (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74, 129–180.
  • Petitet F., Jeantaud B., Reibaud M., Imperato A. and Dubroeucq M. C. (1998) Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors. Life Sci. 63, PL1–PL6.
  • Samali A., Nordgren H., Zhivotovsky B., Peterson E. and Orrenius S. (1999) A comparative study of apoptosis and necrosis in HepG2 cells: oxidant-induced caspase inactivation leads to necrosis. Biochem. Biophys. Res. Commun. 255, 6–11.
  • Samuelsson G. (1999) Drugs of Natural Origin. Swedish Pharmaceutical Press, Stockholm, Sweden.
  • Sandirasegarane L., Herman R. J. and Gopalakrishnan V. (1994) High glucose attenuates peptide agonist-evoked increases in cytosolic free [Ca2+] in rat aortic smooth muscle cells. Diabetes 43, 1033–1040.
  • Terry R. D. (1963) The fine structure of neurofibrillary tangles in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 22, 629–642.
  • Thornberry N. A. and Lazebnik Y. (1998) Caspases: enemies within. Science 281, 1312–1316.
  • Troy C. M., Rabacchi S. A., Xu Z., Maroney A. C., Connors T. J., Shelanski M. L. and Greene L. A. (2001) beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation. J. Neurochem. 77, 157–164.
  • Ueda K., Shinohara S., Yagami T., Asakura K. and Kawasaki K. (1997) Amyloid β-protein potentiates Ca2+ influx through 1-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals. J. Neurochem. 68, 265–271.
    Direct Link:
  • Van der Stelt M., Veldhuis W. B., Van Haaften G. W., Fezza F., Bisogno T., Bar P. R., Veldink G. A., Vliegenthart J. F., Di Marzo V. and Nicolay K. (2001) Exogenous anandamide protects rat brain against acute neuronal injury in vivo. J. Neurosci. 21, 8765–8771.
  • Weiss J. H., Pike C. J. and Cotman C. W. (1994) Ca2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62, 372–375.
    Direct Link:
  • Xiao X. Q., Zhang H. Y. and Tang X. C. (2002) Huperzine A attenuates amyloid beta-peptide fragment 25–35-induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation. J. Neurosci. Res. 67, 30–36.
    Direct Link:
  • Zhou Y., Gopalakrishnan V. and Richardson J. S. (1996) Actions of neurotoxic beta-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists. J. Neurochem. 67, 1419–1425.
    Direct Link:
View Full Article (HTML) Get PDF (227K)